These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6382018)

  • 1. Cancer: mutant ras proteins and cell transformation.
    Newbold R
    Nature; 1984 Aug 23-29; 310(5979):628-9. PubMed ID: 6382018
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
    Spandidos DA
    Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of ras genes in human tumors does not affect localization, modification, or nucleotide binding properties of p21.
    Finkel T; Der CJ; Cooper GM
    Cell; 1984 May; 37(1):151-8. PubMed ID: 6609772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of quantitative liquid competition radioimmunoassays for the ras oncogene and proto-oncogene p21 products.
    Caruso A; Schlom J; Vilasi V; Weeks MO; Hand PH
    Int J Cancer; 1986 Oct; 38(4):587-95. PubMed ID: 3489681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro establishment is not a sufficient prerequisite for transformation by activated ras oncogenes.
    Franza BR; Maruyama K; Garrels JI; Ruley HE
    Cell; 1986 Feb; 44(3):409-18. PubMed ID: 3510745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ras oncogene product p21 is not a regulatory component of adenylate cyclase.
    Beckner SK; Hattori S; Shih TY
    Nature; 1985 Sep 5-11; 317(6032):71-2. PubMed ID: 3929144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation affecting the 12th amino acid of the c-Ha-ras oncogene product occurs infrequently in human cancer.
    Feinberg AP; Vogelstein B; Droller MJ; Baylin SB; Nelkin BD
    Science; 1983 Jun; 220(4602):1175-7. PubMed ID: 6304875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ras gene family.
    Lowy DR; Willumsen BM
    Cancer Surv; 1986; 5(2):275-89. PubMed ID: 3096566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation in ras proto-oncogenes and malignancy.
    Marshall CJ
    J UOEH; 1989 Mar; 11 Suppl():398-405. PubMed ID: 2664953
    [No Abstract]   [Full Text] [Related]  

  • 10. Mutant but not normal p21 ras elevates inositol phospholipid breakdown in two different cell systems.
    Hancock JF; Marshall CJ; McKay IA; Gardner S; Houslay MD; Hall A; Wakelam MJ
    Oncogene; 1988 Aug; 3(2):187-93. PubMed ID: 2842715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical detection of the ras oncogene p21 product in an experimental tumour and in human colorectal neoplasms.
    Williams AR; Piris J; Spandidos DA; Wyllie AH
    Br J Cancer; 1985 Nov; 52(5):687-93. PubMed ID: 3904801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative biochemical properties of normal and activated human ras p21 protein.
    McGrath JP; Capon DJ; Goeddel DV; Levinson AD
    Nature; 1984 Aug 23-29; 310(5979):644-9. PubMed ID: 6147754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental metastasis in nude mice of NIH 3T3 cells containing various ras genes.
    Bradley MO; Kraynak AR; Storer RD; Gibbs JB
    Proc Natl Acad Sci U S A; 1986 Jul; 83(14):5277-81. PubMed ID: 3523488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new verdict for an old convict.
    Pfeifer GP
    Nat Genet; 2001 Sep; 29(1):3-4. PubMed ID: 11528376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. trans-Dominant suppressor mutations of the H-ras oncogene.
    Ogiso Y; Gutierrez L; Wrathall LS; Lu YY; Blair DG; Clanton DJ; Hwang YW; Shih TY
    Cell Growth Differ; 1990 May; 1(5):217-24. PubMed ID: 2150753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of p19 and p21 H-Ras proteins and mutants in miRNA expression in cancer and a Costello syndrome cell model.
    García-Cruz R; Camats M; Calin GA; Liu CG; Volinia S; Taccioli C; Croce CM; Bach-Elias M
    BMC Med Genet; 2015 Jul; 16():46. PubMed ID: 26138095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of N-ras in a human melanoma cell line.
    Padua RA; Barrass NC; Currie GA
    Mol Cell Biol; 1985 Mar; 5(3):582-5. PubMed ID: 3887133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of activated ras oncogenes in human thyroid carcinomas.
    Suárez HG; Du Villard JA; Caillou B; Schlumberger M; Tubiana M; Parmentier C; Monier R
    Oncogene; 1988 Apr; 2(4):403-6. PubMed ID: 3283656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies specific for amino acid 12 of the ras oncogene product inhibit GTP binding.
    Clark R; Wong G; Arnheim N; Nitecki D; McCormick F
    Proc Natl Acad Sci U S A; 1985 Aug; 82(16):5280-4. PubMed ID: 3927300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of normal and transforming H-ras genes in Escherichia coli and purification of their encoded p21 proteins.
    Lacal JC; Santos E; Notario V; Barbacid M; Yamazaki S; Kung H; Seamans C; McAndrew S; Crowl R
    Proc Natl Acad Sci U S A; 1984 Sep; 81(17):5305-9. PubMed ID: 6089191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.